In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
It plans to deliver over 300 million doses to the Indian government
Molnupiravir is an orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2
The company will market it under the brand name Molflu
The company has developed the API in house at its R&D center in Hyderabad
The Home Healthcare market is expected to be US $ 14.2 by 2025
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters
The hospital has recently launched Radionuclide therapy
He has over 22 years of experience in pharmaceutical sales & business development
Subscribe To Our Newsletter & Stay Updated
